Effectiveness and Safety of Pigment Solution Program (PSP) as Adjuvant Therapy in Melasma

Summary

This research is a clinical study with a single-blind randomized clinical trial design (randomized controlled trial) in multicenters at two Dermatology and Venereology Education centers in Indonesia. This study aims to determine the effectiveness and safety of PSP as adjuvant therapy for melasma. This research will be attended by 33 research subjects

Timeline

Start

2023-09-25

Primary completion

2023-12-18

Completion

2023-12-31

Drugs

Indications